KalVista Pharmaceuticals (KALV) EBT Margin Growth (1y) (2015 - 2020)
KalVista Pharmaceuticals (KALV) EBT Margin Growth (1y) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2020 | 18,131.00 |
| Jan 31, 2020 | -75,945.00 |
| Oct 31, 2019 | -18,541.00 |
| Jul 31, 2019 | -9,333.00 |
| Apr 30, 2019 | -31,809.00 |
| Jan 31, 2019 | 3,447.00 |
| Oct 31, 2018 | 45,703.00 |
| Jul 31, 2018 | 601,758.00 |
| Apr 30, 2018 | 439,845.00 |
| Jan 31, 2018 | 307,467.00 |
| Oct 31, 2017 | 149,140.00 |
| Jul 31, 2017 | -568,881.00 |
| Mar 31, 2016 | -2.04 Mn |
| Sep 30, 2015 | -3.97 Mn |
| Jun 30, 2015 | -3.37 Mn |
| Mar 31, 2015 | -4.97 Mn |